Cargando…
Is Platelet Reactivity a Therapeutic Target to Limit Microvascular Obstruction?
Autores principales: | Carberry, Jaclyn, Berry, Colin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238506/ https://www.ncbi.nlm.nih.gov/pubmed/35043662 http://dx.doi.org/10.1161/JAHA.121.024930 |
Ejemplares similares
-
Targeting an Ischemic Time <120 Minutes in ST‐Segment–Elevation Myocardial Infarction
por: Henderson, Matthew, et al.
Publicado: (2019) -
Coronary Thermodilution Waveforms After Acute Reperfused ST‐Segment–Elevation Myocardial Infarction: Relation to Microvascular Obstruction and Prognosis
por: Yew, Shu Ning, et al.
Publicado: (2018) -
Microvascular Obstruction in Acute Myocardial Infarction, a Potential Therapeutic Target
por: Ghobrial, Mina, et al.
Publicado: (2023) -
Post–ST‐Segment–Elevation Myocardial Infarction Platelet Reactivity Is Associated With the Extent of Microvascular Obstruction and Infarct Size as Determined by Cardiac Magnetic Resonance Imaging
por: Massalha, Eias, et al.
Publicado: (2022) -
Risk assessment in patients with an acute ST-elevation myocardial infarction
por: Ahmed, Nadeem, et al.
Publicado: (2016)